A Semiparametric Kernel Independence Test With Application to Mutational Signatures
半参数核独立性检验及其突变特征应用AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要讨论生物医学数据的一般独立性检验,没有充分依据归入所给经济计量细分。
半参数核独立性检验及其突变特征应用AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Cancers arise owing to somatic mutations, and the characteristic combinations of somatic mutations form mutational signatures. Despite many mutational signatures being identified, mutational processes underlying a number of mutational signatures remain unknown, which hinders the identification of interventions that may reduce somatic mutation burdens and prevent the development of cancer. We demonstrate that the unknown cause of a mutational signature can be inferred by the associated signatures with known etiology. However, existing association tests are not statistically powerful due to excess zeros in mutational signatures data. To address this limitation, we propose a semiparametric kernel independence test (SKIT). The SKIT statistic is defined as the integrated squared distance between mixed probability distributions and is decomposed into four disjoint components to pinpoint the source of dependency. We derive the asymptotic null distribution and prove the asymptotic convergence of power. Due to slow convergence to the asymptotic null distribution, a bootstrap method is employed to compute p-values. Simulation studies demonstrate that when zeros are prevalent, SKIT is more resilient to power loss than existing tests and robust to random errors. We applied SKIT to The Cancer Genome Atlas mutational signatures data for over 9000 tumors across 32 cancer types, and identified a novel association between signature 17 curated in the Catalogue of Somatic Mutations in Cancer and apolipoprotein B mRNA editing enzyme (APOBEC) signatures in gastrointestinal cancers. It indicates that APOBEC activity is likely associated with the unknown cause of signature 17. Supplementary materials for this article, including a standardized description of the materials available for reproducing the work, are available as an online supplement.